Trade Summary

3 days ago, Barone Francesca, serving as Chief Scientific Officer at Candel Therapeutics, Inc. (CADL), sold 23,447 shares at $10.06 per share, for a total transaction value of $235,768.96. Following this transaction, Barone Francesca now holds 77,362 shares of CADL.

This sale represents a 23.26% decrease in Barone Francesca's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Monday, June 29, 2026 and publicly disclosed via SEC Form 4 filing on Wednesday, July 1, 2026 at 4:22 PM ET, 2 days after the trade was made.

Candel Therapeutics, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.